Showing results (311-320 of 1,750) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
A pilot study of denileukin diftitox (DD) in combination with high-dose interleukin-2 (IL-2) for patients with metastatic renal cell carcinoma (RCC)Elizabeth Atchison, John Eklund, Brenda Martone, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansionDongxia Xing, Alan G Ramsay, John G Gribben, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Prevention of interleukin-2 withdrawal-induced apoptosis in lymphocytes retrovirally cotransduced with genes encoding an antitumor T-cell receptor and an antiapoptotic proteinAnusha Kalbasi, Rajeev K Shrimali, Dhanalakshmi Chinnasamy, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Meeting report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010Gregory B Lesinski, William E Carson, Elizabeth A Repasky, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 7, 2010
Preclinical evaluation of a recombinant anti-prostate specific membrane antigen single-chain immunotoxin against prostate cancerPhilipp Wolf, Karen Alt, David Wetterauer, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 7, 2010
Effect of IL-18 on expansion of gammadelta T cells stimulated by zoledronate and IL-2Wen Li, Shuji Kubo, Akico Okuda, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 18, 2011
Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanomaSofie Wilgenhof, An M T Van Nuffel, Jurgen Corthals, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 2, 2011
Ipilimumab increases activated T cells and enhances humoral immunity in patients with advanced melanomaJeffrey S Weber, Omid Hamid, Scott D Chasalow, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 13, 2011
Augmented lymphocyte expansion from solid tumors with engineered cells for costimulatory enhancementKevin M Friedman, Laura E Devillier, Steven A Feldman, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
Improving T-cell immunotherapy for melanoma through a mathematically motivated strategy: efficacy in numbers?Natalie Kronik, Yuri Kogan, Paul G Schlegel, et al.Pageof 175